Bolden Therapeutics pursues pharmaceutical research to combat neurodegenerative diseases
By Anna Kim | April 24Bolden Therapeutics is a biotechnology company that develops therapeutics to promote the birth of new neurons in the adult brain for potential treatment of neurological diseases such as Alzheimer’s disease. The company arose from a collaboration between the Fallon Lab and the Webb Lab and works ...